Literature DB >> 8363196

Proposed standards for judging the success of the treatment of obesity.

R L Atkinson1.   

Abstract

The purpose of this report is to propose standards for the successful treatment of obesity. This process is somewhat arbitrary because obesity is a multifactorial disease and because standards need revision as diagnostic and treatment techniques improve. Weight loss, the classic standard of success, does not account for individual variability. Reduction in other measures of body size, such as body mass index, percentage of excess weight, and body fat, may be preferable. Improvement in known complications of obesity (diabetes mellitus, hypertension, hyperlipoproteinemia, sleep apnea, and psychosocial problems) are equally valid measures of success. Because obesity is a chronic disease, maintenance of weight loss is included as a standard of success. Response to obesity treatment varies, and thus criteria to define minimal, intermediate, and full success for each variable are necessary.

Entities:  

Mesh:

Year:  1993        PMID: 8363196     DOI: 10.7326/0003-4819-119-7_part_2-199310011-00010

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  4 in total

1.  Culturally-sensitive weight loss program produces significant reduction in weight, blood pressure, and cholesterol in eight weeks.

Authors:  J D Ard; R Rosati; E Z Oddone
Journal:  J Natl Med Assoc       Date:  2000-11       Impact factor: 1.798

Review 2.  Effective diet and exercise treatments for overweight and recommendations for intervention.

Authors:  W C Miller
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 3.  A review of unmet needs in obesity management.

Authors:  N Nguyen; J K Champion; J Ponce; B Quebbemann; E Patterson; B Pham; W Raum; J N Buchwald; G Segato; F Favretti
Journal:  Obes Surg       Date:  2012-06       Impact factor: 4.129

4.  Weight loss and weight loss maintenance in African-American women.

Authors:  Jacqueline A Walcott-McQuigg; Shu-Pi Chen; Kara Davis; Ernestine Stevenson; Aeree Choi; Suparat Wangsrikhun
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.